August 5, 2015

Britain raps Pfizer over huge jump in epilepsy drug price

Britain's competition watchdog has accused Pfizer and Flynn Pharma of breaching UK and European law by ramping up the cost of an epilepsy drug, given to more than 50,000 British patients, by as much as 2,600 percent.

The Competition and Markets Authority (CMA) said its provisional view was that Pfizer and Flynn Pharma each abused... Read more.

Reuters

Related,
Pfizer and Flynn overcharged NHS by millions, says watchdog - Telegraph
Pfizer in VK beschuldigd van manipulatie medicijnprijs - NRC

No comments:

Post a Comment